Lazcluze 80 mg (Lazertinib (Lazertinib Mesylate) TABLET) 80 MG

LAZCLUZE 80 MG tablets contain lazertinib mesylate, a targeted therapy option for certain cancer treatments. This medication is designed to inhibit specific proteins involved in cancer cell growth.

Strength

80 MG

Manufacturer / TM Owner

JANSSEN INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

LAZCLUZE 80 MG tablets are primarily used in the treatment of non-small cell lung cancer (NSCLC). This medication targets specific mutations in the EGFR protein, which can drive the growth of cancer cells. Patients may wonder, 'What is LAZCLUZE used for?' It is typically prescribed for advanced or metastatic NSCLC with specific EGFR mutations.

Side Effects

Common effects of LAZCLUZE 80 MG tablets may include nausea, diarrhea, and fatigue. Some patients might experience skin reactions or changes in liver function. These effects can vary widely among individuals, and not everyone will experience them.

Precautions & Warnings

LAZCLUZE 80 MG tablets should be handled with care, following the guidance of a healthcare provider. It is important to monitor liver function regularly while taking this medication. Patients should avoid grapefruit or grapefruit juice, as it can affect how the body processes lazertinib.

Avoid Interactions

LAZCLUZE 80 MG tablets may interact with certain medications, including those that affect liver enzymes like CYP3A. Alcohol and other substances that impact liver function should be avoided. Always inform your healthcare provider about all medications and supplements you are taking.

Frequently Asked Questions

LAZCLUZE 80 MG tablets are used to treat non-small cell lung cancer (NSCLC) with specific EGFR mutations.

LAZCLUZE 80 MG tablets are taken orally, typically once daily, as prescribed by a healthcare provider.

Common side effects may include nausea, diarrhea, fatigue, and skin reactions.

It is generally advised to avoid alcohol while taking LAZCLUZE 80 MG tablets, as it may affect liver function.

If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular schedule.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.